Sarepta Therapeutics
SRPT
SRPT
179 hedge funds and large institutions have $1.21B invested in Sarepta Therapeutics in 2017 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 64 increasing their positions, 44 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
179
Holders Change
+2
Holders Change %
+1.13%
% of All Funds
4.46%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
39
Increased
64
Reduced
44
Closed
28
Calls
$108M
Puts
$54.9M
Net Calls
+$53.5M
Net Calls Change
+$36.4M
Top Buyers
| 1 |
BlackRock
New York
|
+$153M |
| 2 |
HM
HealthCor Management
New York
|
+$45.9M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$40M |
| 4 |
O
OrbiMed
New York
|
+$31.2M |
| 5 |
PC
PointState Capital
New York
|
+$18.9M |
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$55.3M |
| 2 |
PA
Perceptive Advisors
New York
|
-$29.6M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$27.7M |
| 4 |
JG
Jefferies Group
New York
|
-$23M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$16.7M |
